Connect your AI

Tenet Healthcare THC Net Losses on Sale, Consolidation, And Deconsolidation Of Facilities

Other financials

Income statement

Revenue$5.4B+2.8%

Operating income$1.3B+37.4%

Net income$906.0M+45.7%

EPS (diluted)$8.01+87.6%

Balance sheet

Cash & equivalents$3.0B-1.1%

Total debt$13.3B+0.2%

Total equity$4.8B+15.1%

Total assets$31.2B+6.7%

Cash flow

Operating cash flow$1.6B+101%

CapEx$180.0M+4.0%

Free cash flow$1.5B+128%

Valuation

Market cap$14.86B—

Enterprise value$25.19B—

P/E5.6×—

P/S0.7×—

Profitability

Operating margin18%+0.4pp

Net margin12.4%+0.9pp

FCF margin15.6%—

Returns & leverage

Return on equity58.9%-2.7pp

Debt / equity2.8×-0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Tenet Healthcare in its filing.

Tagged under the XBRL concept thc:NetLossesOnSaleConsolidationAndDeconsolidationOfFacilities.

The official record: Tenet Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tenet Healthcare's net losses on sale, consolidation, and deconsolidation of facilities.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Tenet Healthcare's net losses on sale, consolidation, and deconsolidation of facilities?: Tenet Healthcare (THC) reported net losses on sale, consolidation, and deconsolidation of facilities of $1M in Q1 2026.
How has Tenet Healthcare's net losses on sale, consolidation, and deconsolidation of facilities changed year-over-year?: Tenet Healthcare's net losses on sale, consolidation, and deconsolidation of facilities decreased by 95.5% year-over-year, from $22M to $1M.